What the company actually pays, and whether its own cash supports it.
Dividends view
Yield
3.81%Above 5Y avg (2.76%)
Annual Rate
BRL 0.91Paid quarterly
Payout Ratio
75.5%Moderate
Payback Period
16.4 yr
Last Ex-Dividend
Sep 23, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
118.33BBRL
21.50B · vs all stocks (USD)
Updated Oct 24, 2026
Trailing P/E
23.65x
Updated Oct 24, 2026
Revenue (TTM)
10.78BBRL
1.96B · vs all stocks (USD)
Updated Oct 24, 2026
Profit Margin
49.45%
Updated Oct 24, 2026
Beta
0.0730x
vs all stocks
Updated Oct 24, 2026
52-Week Change
88.75%
vs all stocks
Updated Oct 24, 2026
Forward Annual Dividend Yield
3.81%
vs all stocks
Updated Oct 24, 2026
Market Capitalization
118.33BBRL
21.50B · vs all stocks (USD)
Updated Oct 24, 2026
Enterprise Value
118.04BBRL
21.44B · vs all stocks (USD)
Updated Oct 24, 2026
Trailing P/E
23.65x
Updated Oct 24, 2026
Forward P/E
17.57x
Updated Oct 24, 2026
PEG Ratio
0.7111x
Updated Oct 24, 2026
Price to Sales (TTM)
10.92x
Updated Oct 24, 2026
Price to Book (MRQ)
6.32x
Updated Oct 24, 2026
Enterprise to Revenue
10.95x
Updated Oct 24, 2026
Enterprise to EBITDA
16.26x
Provider-reported. Enterprise Value ÷ EBITDA (TTM) on this page gives 14.36×.Updated Oct 24, 2026
Gross Margin
71.47%
Provider-reported. Gross Profit (TTM) ÷ Revenue (TTM) on this page gives 95.1%.Updated Oct 24, 2026
Profit Margin
49.45%
Updated Oct 24, 2026
Operating Margin
64.72%
Updated Oct 24, 2026
Return on Assets (TTM)
9.25%
Updated Oct 24, 2026
Return on Equity (TTM)
27.71%
Updated Oct 24, 2026
Revenue (TTM)
10.78BBRL
1.96B · vs all stocks (USD)
Updated Oct 24, 2026
Revenue per Share (TTM)
2.12BRLUpdated Oct 24, 2026
Quarterly Revenue Growth
8.80%
Updated Oct 24, 2026
Gross Profit (TTM)
10.25BBRL
1.86B · vs all stocks (USD)
Updated Oct 24, 2026
EBITDA (TTM)
8.22BBRL
1.49B · vs all stocks (USD)
Updated Oct 24, 2026
Net Income (TTM)
5.33BBRL
968.14M · vs all stocks (USD)
Updated Oct 24, 2026
Quarterly Earnings Growth (YoY)
28.20%
Updated Oct 24, 2026
Operating Cash Flow (TTM)
5.98BBRL
1.09B · vs all stocks (USD)
Updated Oct 24, 2026
Levered Free Cash Flow (TTM)
4.28BBRL
777.02M · vs all stocks (USD)
Updated Oct 24, 2026
Forward Annual Dividend Rate
0.9065BRLUpdated Oct 24, 2026
Forward Annual Dividend Yield
3.81%
vs all stocks
Updated Oct 24, 2026
Trailing Annual Dividend Rate
0.9026BRLUpdated Oct 24, 2026
Trailing Annual Dividend Yield
3.80%
vs all stocks
Updated Oct 24, 2026
5-Year Average Dividend Yield
2.76%
vs all stocks
Updated Oct 24, 2026
Payout Ratio
75.51%
Provider-reported. Trailing Annual Dividend Rate ÷ Diluted EPS (TTM) on this page gives 90.26%.Updated Oct 24, 2026
Minority Interest (Equity)
21.95MBRLFY2025 · Dec 31, 2025
Revenue
10.07BBRLFY2025 · Dec 31, 2025
Cost of Goods Sold
2.67BBRLFY2025 · Dec 31, 2025
Gross Profit
7.40BBRLFY2025 · Dec 31, 2025
Operating Income
6.54BBRL
1.19B · vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
6.95BBRLFY2025 · Dec 31, 2025
Income Tax Expense
2.36BBRLFY2025 · Dec 31, 2025
Net Income
4.59BBRLFY2025 · Dec 31, 2025
EBIT
8.67BBRLFY2025 · Dec 31, 2025
EBITDA (Income Statement)
7.00BBRLFY2025 · Dec 31, 2025
Selling, General & Administrative
234.51MBRLFY2025 · Dec 31, 2025
Other Operating Expenses
221.68MBRLFY2025 · Dec 31, 2025
Non-operating Interest Income
31.88MBRLFY2025 · Dec 31, 2025
Non-operating Interest Expense
1.72BBRLFY2025 · Dec 31, 2025
EPS (Basic)
0.8379BRLFY2025 · Dec 31, 2025
EPS (Diluted)
0.8344BRLFY2025 · Dec 31, 2025
Basic Shares Outstanding
5.18BSharesFY2025 · Dec 31, 2025
Diluted Shares Outstanding
5.18BSharesFY2025 · Dec 31, 2025
Net Income from Continuing Operations
4.59BBRLFY2025 · Dec 31, 2025
Minority Interests (P&L)
-1.25MBRLFY2025 · Dec 31, 2025
Preferred Stock Dividends
0.00BRLFY2025 · Dec 31, 2025
Operating Cash Flow
3.33BBRLFY2025 · Dec 31, 2025
Free Cash Flow
3.18BBRLFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
351.40MBRLFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
4.59BBRLFY2025 · Dec 31, 2025
Stock-based Compensation
98.48MBRLFY2025 · Dec 31, 2025
Other Non-cash Items
1.76BBRLFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
85.69MBRLFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
-3.20BBRLFY2025 · Dec 31, 2025
Capital Expenditures
-144.66MBRLFY2025 · Dec 31, 2025
Net Intangibles (CF)
-142.03MBRLFY2025 · Dec 31, 2025
Net Acquisitions
-44.44MBRLFY2025 · Dec 31, 2025
Other Investing Activity
1.60MBRLFY2025 · Dec 31, 2025
Net Investing Cash Flow
-187.50MBRLFY2025 · Dec 31, 2025
Long-term Debt Issuance
4.57BBRLFY2025 · Dec 31, 2025
Long-term Debt Payments
-2.57BBRLFY2025 · Dec 31, 2025
Common Stock Repurchase
-3.01BBRLFY2025 · Dec 31, 2025
Other Financing Charges
-27.63MBRLFY2025 · Dec 31, 2025
Net Financing Cash Flow
-1.04BBRLFY2025 · Dec 31, 2025
Shares Outstanding
5.00BSharesUpdated Oct 24, 2026
Float Shares
5.00BSharesUpdated Oct 24, 2026
% Held by Insiders
0.00%
vs all stocks
Updated Oct 24, 2026
% Held by Institutions
68.30%
vs all stocks
Updated Oct 24, 2026
Total Cash (MRQ)
15.66BBRL
2.85B · vs all stocks (USD)
Updated Oct 24, 2026
Total Cash per Share (MRQ)
3.13BRLUpdated Oct 24, 2026
Total Debt (MRQ)
15.47BBRL
2.81B · vs all stocks (USD)
Updated Oct 24, 2026
Total Debt to Equity (MRQ)
0.8257x
Updated Oct 24, 2026
Current Ratio (MRQ)
1.92x
Updated Oct 24, 2026
Book Value per Share (MRQ)
3.74BRLUpdated Oct 24, 2026
Total Assets
48.49BBRL
8.81B · vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
17.71BBRLFY2025 · Dec 31, 2025
Total Liabilities
31.02BBRLFY2025 · Dec 31, 2025
Total Non-current Assets
30.78BBRLFY2025 · Dec 31, 2025
Total Non-current Liabilities
21.73BBRLFY2025 · Dec 31, 2025
Total Current Liabilities
9.29BBRLFY2025 · Dec 31, 2025
Cash
351.40MBRLFY2025 · Dec 31, 2025
Cash Equivalents
1.25BBRLFY2025 · Dec 31, 2025
Cash & Cash Equivalents
1.60BBRLFY2025 · Dec 31, 2025
Other Short-term Investments
13.93BBRLFY2025 · Dec 31, 2025
Accounts Receivable
618.34MBRLFY2025 · Dec 31, 2025
Accounts Payable
390.81MBRLFY2025 · Dec 31, 2025
Short-term Debt
1.31BBRLFY2025 · Dec 31, 2025
Other Current Liabilities
4.47BBRLFY2025 · Dec 31, 2025
Long-term Debt
14.07BBRLFY2025 · Dec 31, 2025
Other Non-current Liabilities
235.42MBRLFY2025 · Dec 31, 2025
Common Stock (Book)
12.90BBRLFY2025 · Dec 31, 2025
Total Shareholders' Equity
17.46BBRL
3.17B · vs all stocks (USD)
FY2025 · Dec 31, 2025
Treasury Stock
2.98BBRLFY2025 · Dec 31, 2025
52-Week Low
12.41BRLUpdated Oct 24, 2026
52-Week High
24.28BRLUpdated Oct 24, 2026
52-Week Change
88.75%
vs all stocks
Updated Oct 24, 2026
Beta
0.0730x
vs all stocks
Updated Oct 24, 2026
50-Day MA
18.73BRLUpdated Oct 24, 2026
200-Day MA
17.17BRLUpdated Oct 24, 2026
Avg 10-Day Volume
53.57MSharesUpdated Oct 24, 2026
Avg 30-Day Volume
54.24MSharesUpdated Oct 24, 2026
Diluted EPS (TTM)
1.00BRLUpdated Oct 24, 2026
2 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Ulcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
It sits well below its peak, and the fall has been both deep and long.
Partial Recovery After Sharp Decline
A weak, thin-volume bounce inside a decline that is still far from recovered.
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.